Fresh analysis reveals that people who come off popular slimming jabs like semaglutide or tirzepatide tend to recover reduced body mass far faster than those who end conventional diet and exercise programs.
Findings released in a prominent medical journal demonstrates that while overweight people often shed a large proportion of their total mass while on the medication, the weight comes back at an average rate of nearly a kilo each month once they quit.
"Individuals buying such drugs must be cognizant of the potential of rapid weight regain when the treatment concludes," warns lead investigator Dr. Susan Jebb.
Such speed of recovery suggests a return to original weight within about 18 months.
Comparing Treatments
The research, which examined 37 of studies involving over 9,000 of participants, compared the results of the injectable medications with other pills.
Researchers emphasize that people who shed pounds through diet and exercise usually see a more gradual weight regain—perhaps 100 grams monthly—once they finish.
Understanding the Rapid Regain
Doctors suggest the mechanism of the drugs is key to understanding the amplified rebound.
GLP-1 drugs mimic a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.
"Sustained high doses of GLP-1 concentrations far above than the body's typical production could lead to the system to produce less of its own natural hormone, and may also lessen sensitivity to its actions," explained Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this hormone supplement results in hunger is uncontrolled, making binge eating much more probable."
A Lifelong Condition?
Medical guidelines suggest the injections for individuals with obesity-related medical conditions, accompanied by prescribed lifestyle changes.
A number of clinicians contend that, considering the likelihood of weight regain, the therapy might need to be ongoing.
This opinion is reinforced by pharmaceutical companies, who say that the results "emphasize the chronic character of excess weight," comparing it to managing conditions like high blood pressure.
User Accounts
Individuals who have stopped the medication report a sudden return of hunger.
"It felt as if a trigger activating and you become ravenous," described an individual.
This difficulty is exacerbated if patients have not adopted lasting dietary or behavioural modifications during therapy.
Growing Interest
Survey data show that a significant number of people in the UK have used these injections in the past year, with demand being substantial.
- Use is greater among females than males.
- The middle-aged age group shows the greatest level of interest.
- Many access the medications through private prescriptions rather than the NHS.
In conclusion, researchers stress that while the jabs are potent tools for shedding pounds, they are not a permanent cure and long-term success relies on ongoing behavioural changes.
